2ONE Labs Receives PMTA 'Acceptance' for 2ONE® Nicotine Pouch brand from FDA Center for To
LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) - 2ONE Labs Inc., is pleased to announce the 'Acceptance' of its Premarket Tobacco Product Application (PMTA) submission by the U.S. Food and Drug Administration for its 2ONE® branded nicotine pouches.
Acknowledging receipt of the FDA ‘Acceptance’ notification, Vincent Schuman, CEO of 2ONE Labs, said: “This means the 2ONE® PMTA application will now move forward to the next important stage of FDA review. Our company will continue to fully fund this submission to a successful conclusion, and our wholesale, retail and sponsorship partners should take confidence in this ‘Acceptance’ as a sign of our ability to navigate this complex PMTA process, and of our unwavering commitment to support the long-term availability of the 2ONE® brand in the US market.”
Schuman added: “We created 2ONE® nicotine pouches for adult users (21+), who find it challenging to switch from combustible or traditional oral tobacco-leaf products. The availability of the 2ONE® brand in the market over the past 5 years, and the interest and growth our brand has achieved through strong retail partnerships, such as with CircleK®, has shown it is possible - even for innovative companies - to identify and introduce unique brands that truly offer adults the perfect switching product. We are encouraged by FDA’s acceptance of the 2ONE® PMTA submission and we look forward to continuing to support the needs of adult consumers switching from tobacco.”
2ONE® nicotine pouch products are offered in a variety of nicotine levels and satisfying flavors at over 18,000 retail outlets nationwide, and can be purchased online by adult consumers at: 21Pouches.com.
About 2ONE® Nicotine Pouches
2ONE Labs Inc.: Founded by pioneers in synthetic nicotine production, 2ONE Labs specializes in providing the most innovative tobacco-free nicotine products to adult consumers seeking an alternative to other tobacco products. For more information, contact 21Pouches.com. 2ONE® is a registered trademark of 2ONE Labs Inc., Lake Tahoe, NV. All Rights Reserved.
Source: 2ONE LABS INC.
Contact:
Vincent@21pouches.com
- MediaCo收购Estrella Media的内容和数字业务
- Sandoz receives FDA approval for first and only denosumab biosimilars
- 给细胞补水除病科学治本造福万代专访我国用水祛病的发明家陆江
- HMC6832ALP5LETR: Revolutionizing Microwave Control Systems with Precision and Efficiency | ChipsX
- 第三届闽江白内障青光眼新技术培训班即将在榕举办(线上同步直播)
- 广东共能:模温机与其他温控设备相比有哪些优点
- 亿固携发明专利金钢瓷砖胶产品布局江苏徐州,为华东业主带来安居体验
- 第25届全州国际电影节将于5月1日在韩国全州拉开帷幕
- 顾家星选亮相住宅产业年会:进阶中的星选定制如何赋能装企
- PUBG正式公布与 NewJeans 联动 专属游戏道具亮相
- 跨界谋发展,跨境创未来,海比电商「涌动制造」,让世界看见中国制造
- 共享电单车哪家比较有名?人民出行共享电单车
- 华发物业服务:私有化决议案获高票通过 9月23日下午四时正式撤销联交所上市地位
- Myrobalan Therapeutics 任命 Grant Bogle 为董事会成员
- 知名演员黄宥明否认与朱梓骁恋情
- Bitget's Protection Fund in September Sustained Above Initial $300M Commitment Amidst Market Vo
- 香港股票分析师协会组织「香港金融界前海交流团」
- 用友烟草:AI+成就数智烟草企业
- 庆“八一”爱国拥军表彰联谊会在北京盛大开幕
- 黎京雄院长精彩亮相第十七届“美沃斯大会”,实操示教:Fotona4DPro眶周分层抗衰
- Bureau Veritas: Strong Start to the Year; 2024 Outlook Confirmed
- 新创建集团引领 ESG 新时代:Evolve Conference 2024 暨 Imp[ACT] Fund获奖者揭晓
- 中国开源软件推进联盟携手IBM发布《可信赖的企业级生成式AI白皮书》
- 以人为本,骊享未来 骊住水科技集团亮相第28届国际厨卫展
- Medidata 与赛诺菲疫苗扩大合作,践行以患者为中心并提升试验效率
- 港大ICB 东非游学精彩回顾:探寻神秘大陆,邂逅不一样的自己
- 钱江潮涌激荡未来新趋势,智杰云集共绘AI新蓝图 | 2024钱江潮产学研合作创新论坛顺利召开
- MBA新精英·筑梦报考季,北京高校招生政策宣讲会顺利举办!
- 张亚雄荣获“金砖艺术家” 荣誉称号
- “共享创新 共赢未来”杭甬双城产融合作大会暨高层次人才项目路演圆满完成
推荐
- 大家一起关注新疆乌什7.1级地震救援见闻 看到热气腾腾的抓饭马上就要出锅、村里大家 资讯
- 中国减排方案比西方更有优势 如今,人为造成的全球变暖是每个人都关注的问 资讯
- 一个“江浙沪人家的孩子已经不卷学习了”的新闻引发议论纷纷 星标★ 来源:桌子的生活观(ID:zzdshg) 没 资讯
- 新增供热能力3200万平方米 新疆最大热电联产项目开工 昨天(26日),新疆最大的热电联产项目—&md 资讯
- 看新东方创始人俞敏洪如何回应董宇辉新号分流的? (来源:中国证券报) 东方甄选净利润大幅下滑 资讯
- 私域反哺公域一周带火一家店! 三四线城市奶茶品牌茶尖尖两年时间做到GMV 资讯
- 奥运冠军刘翔更新社交账号晒出近照 时隔473天更新动态! 2月20日凌晨2点,奥运冠军刘翔更新社交账号晒 资讯
- 海南大学生返校机票贵 有什么好的解决办法吗? 近日,有网友在“人民网领导留言板&rdqu 资讯
- 周星驰新片《少林女足》在台湾省举办海选,吸引了不少素人和足球爱好者前来参加 周星驰新片《少林女足》在台湾省举办海选,吸 资讯
- 国足13次出战亚洲杯首次小组赛0进球 北京时间1月23日消息,2023亚洲杯小组 资讯